Man Group’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Buy
72,182
+23,725
+49% +$1M ﹤0.01% 1500
2025
Q4
$2.24M Sell
48,457
-45,455
-48% -$1.9M ﹤0.01% 1410
2025
Q3
$3.29M Buy
93,912
+15,661
+20% +$544K 0.01% 1235
2025
Q2
$2.31M Sell
78,251
-26,636
-25% -$760K ﹤0.01% 1352
2025
Q1
$3.13M Sell
104,887
-113,545
-52% -$3.47M 0.01% 1194
2024
Q4
$6.26M Sell
218,432
-122,142
-36% -$4.04M 0.02% 933
2024
Q3
$13.2M Sell
340,574
-36,851
-10% -$1.31M 0.03% 611
2024
Q2
$12.2M Buy
377,425
+116,489
+45% +$4.04M 0.03% 623
2024
Q1
$10.1M Buy
260,936
+204,957
+366% +$7.17M 0.03% 692
2023
Q4
$1.72M Buy
+55,979
New +$1.4M ﹤0.01% 1320
2023
Q3
Sell
-43,100
Closed -$983K 1255
2023
Q2
$926K Buy
+43,100
New +$979K ﹤0.01% 1408
2021
Q1
Sell
-20,470
Closed -$410K 1867
2020
Q4
$410K Sell
20,470
-1,500
-7% -$29.3K ﹤0.01% 1591
2020
Q3
$457K Sell
21,970
-1,953
-8% -$35.3K ﹤0.01% 1562
2020
Q2
$419K Sell
23,923
-8,508
-26% -$167K ﹤0.01% 1492
2020
Q1
$530K Buy
+32,431
New +$669K ﹤0.01% 1270
2018
Q4
Sell
-19,445
Closed -$287K 1948
2018
Q3
$287K Buy
+19,445
New +$345K ﹤0.01% 1966

Other funds holding COLL

Man Group's COLL Position: Q1 2026 in Review

Man Group increased its Collegium Pharmaceutical (COLL) stake by 49% in Q1 2026, buying an estimated $1M and bringing the position to 72,182 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

Man Group first reported a position in COLL in Q3 2018 and has held it in 16 quarters since. The position peaked at $13.2M in Q3 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Man Group held 72,182 shares of Collegium Pharmaceutical worth $2.39M as of Q1 2026.
  • Man Group bought 23,725 Collegium Pharmaceutical shares in Q1 2026, an estimated $1M.
  • Collegium Pharmaceutical made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #1500 holding.
  • Man Group first reported a position in Collegium Pharmaceutical in Q3 2018 and has held it in 16 quarters since.
  • Man Group's Collegium Pharmaceutical position peaked at $13.2M in Q3 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.